Whereas these studies looked at patients with various stages of breast cancer, our objective was to explore the value of macrophage densities as an independent prognostic biomarker in early stage hormone receptor-positive (HR+) breast cancer. This evidence concerns the gene NR4A1 and breast carcinoma.